Ubs Asset Management Americas Inc Biogen Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Biogen Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,533,813 shares of BIIB stock, worth $183 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,533,813
Previous 1,152,691
33.06%
Holding current value
$183 Million
Previous $223 Million
4.97%
% of portfolio
0.06%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding BIIB
# of Institutions
1,015Shares Held
127MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.92 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.74 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$884 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$442 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...